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The 5 stem-loop is a conserved sequence element
found around the translation initiation site of three col-
lagen mRNAs, 1(I), 2(I), and 1(III). We show here that
the 5 stem-loop of collagen 1(I) mRNA is inhibitory to
translation in vitro. The sequence 5 to the translation
initiation codon, as a part of the 5 stem-loop, is also not
efficient in initiating translation under competitive con-
ditions. This suggests that collagen 1(I) mRNA may not
be a good substrate for translation. Since the 5 stem-
loop binds protein factors in collagen-producing cells,
this binding may regulate its translation in vivo. We
studied in vivo translation of collagen 1(I) mRNA after
transfecting collagen 1(I) genes with and without the 5
stem-loop into Mov 13 fibroblasts. The mRNA with the
1(I) 5 stem-loop was translated into pepsin-resistant
collagen, which was secreted into the cellular medium.
This mRNA also produced more disulfide-bonded high
molecular weight collagen found intracellularly. The
mRNA in which the 5 stem-loop was mutated, but with-
out affecting the coding region of the gene, was trans-
lated into pepsin-sensitive collagen and produced only
trace amounts of disulfide-bonded collagen. This sug-
gests that the 5 stem-loop is required for proper folding
or stabilization of the collagen triple helix. To our
knowledge this is the first example that an RNA element
located in the 5-untranslated region is involved in syn-
thesis of a secreted multisubunit protein. We suggest
that 5 stem-loop, with its cognate binding proteins, tar-
gets collagen mRNAs for coordinate translation and
couples translation apparatus to the rest of the collagen
biosynthetic pathway.
Three fibrillar collagen mRNAs, 1(I), 2(I), and 1(III), are
coordinately regulated in fibrotic processes of various organs
(1, 2). In the 5-UTR1 of these mRNAs there is a stem loop
structure (5 stem-loop) encompassing the translation initia-
tion codon (3). The 5 stem-loop is located about 75 nt from the
cap and has a stability of G  25–30 kcal/mol. The 5 stem-
loop is well conserved in evolution, differing by only two nucle-
otides in Xenopus and human collagen mRNAs (4). The se-
quence flanking the 5 stem-loop is not conserved. A similar
stem-loop structure is also found around the translation start
codon of the sea urchin collagen gene (5). Evolutionary conser-
vation of this sequence suggests an important function.
We analyzed previously a regulatory role of the 5 stem-loop
in two experimental systems; quiescent versus activated he-
patic stellate cells (HSCs) (6) and fibroblasts cultured in a
three-dimensional matrix (7). Activated HSCs are responsible
for excessive collagen production in liver fibrosis (8, 9). We
found that the 5 stem-loop prevented expression of the re-
porter genes in quiescent HSCs, which express low amounts of
type I collagen, but allowed for expression in activated HSCs.
This inhibitory effect of the 5 stem-loop was in part mediated
by a decreased half-life of the corresponding mRNAs. Reporter
genes with the mutated 5 stem-loop were constitutively ex-
pressed to a high level in both cell types. Therefore, expression
of the reporter mRNA with the 5 stem-loop resembles expres-
sion of endogenous collagen 1(I) mRNA in HSCs; it is low in
quiescent HSCs and elevated in activated HSCs and regulated
by a post-transcriptional mechanism (6).
Second, we studied the role of the 5 stem-loop on collagen
1(I) mRNA expression in fibroblasts cultured in a three-di-
mensional matrix where the fibroblasts revert from an acti-
vated phenotype to a more quiescent phenotype. This is accom-
panied by destabilization of endogenous collagen 1(I) mRNA
(10). The reporter collagen 1(I) mRNA with the intact 5
stem-loop was less stable than the identical mRNA with the
mutated 5 stem-loop in the cells grown in the matrix. Thus,
the 5 stem-loop is required for accelerated decay of collagen
1(I) mRNA in cells that down-regulate collagen synthesis (7).
The mechanism by which the 5 stem-loop targets mRNAs
for turnover in HSCs and fibroblasts grown in a three-dimen-
sional matrix is unknown. In quiescent HSCs we could not
detect any protein binding to the 5 stem-loop in vitro. In
activated HSCs a cytosolic protein factor(s) of unknown iden-
tity binds to the stem-loop and requires a 7mG cap on the RNA
for binding (6). An excess of cap analogue completely prevents
formation of this complex in vitro. The complex is also found in
fibroblasts in postpolysomal cytoplasmic fraction. Its binding is
greatly reduced if the cells are cultured in a three-dimensional
matrix (7). One possibility is that the 5 stem-loop binding
activity may increase the steady-state level of collagen mRNAs
by diverting them from the degradative pathway (11).
Translation and mRNA decay are coupled processes (12).
Therefore, studies on the translation of collagen 1(I) mRNA
are required to provide insight into the mechanism of stabili-
zation of this mRNA. All collagen 1(I) mRNA is associated
with membrane-bound polysomes and is not found on free
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polysomes or in postpolysomal supernatant.2 It is not known if
this association is because of targeting of the mRNA or target-
ing by the leader peptide after initiation of translation. Colla-
gens are secreted proteins, and their translation is coupled to
export of the peptides into the endoplasmic reticulum (13).
There is substantial evidence that all three peptides initiate
folding into the heterotrimer while still associated with poly-
somes on the endoplasmic reticulum (14–17). When folding is
initiated, the collagen trimer is released in the lumen of the
endoplasmic reticulum. In human disease osteogenesis imper-
fecta (OI) certain mutations of 1(I) chain decrease the rate of
assembly of collagen type I. Unassembled OI 1(I) chains are
hypermodified on proline and lysine residues and degraded (18,
19). This suggests that modification and assembly processes
are in a kinetic equilibrium. It is possible that the 5 stem-loop
binding activity may target collagen mRNAs to translation at
such sites.
In this study we investigate the role of the 5 stem-loop in
translation of collagen 1(I) mRNA in vitro and in vivo. We
found that the 5 stem-loop inhibits translation in vitro and
when more than one mRNA is competing for a limited amount
of translational apparatus. In fibroblasts in vivo, the 5 stem-
loop is necessary for efficient folding or synthesis of stable
triple helical collagen. To our knowledge this is the first exam-
ple of an RNA element that affects protein folding.
MATERIALS AND METHODS
Constructs—Plasmid used for in vitro transcription of PSII mRNA
was constructed by cloning of the double-stranded oligonucleotide with
the sequence shown in Fig. 1B into HindIII and NarI sites of the pGL3
vector (Promega). Then, the double-stranded oligonucleotide with the
sequence of the T7 promoter was cloned into BglII-HindIII sites of the
above construct. This plasmid was linearized with HpaI and tran-
scribed in vitro with T7 polymerase and Cap-scribe kit (Roche Molecu-
lar Biochemicals) to produce capped PSII mRNA. COLL-START and
COLL-OPTSTART constructs were made by cloning double-stranded
oligonucleotides with the sequence shown in Fig. 1B into SacI-NarI
sites of pGL3 and recloning of the EcoRI-HpaI fragment into EcoRI-
SmaI sites of the pGEM3 vector (Promega). After linearization with
BamHI corresponding capped mRNAs were synthesized with T7 polym-
erase and the Cap-scribe kit. Plasmids for synthesis of the 5 WT-SL
and 5 MUT-SL mRNAs were made by cloning of double-stranded
oligonucleotides with the sequence shown in Fig. 2A into the HindIII-
NarI site of the pGL3 vector and cloning of the T7 promoter as for PSII.
Capped mRNAs were made as described for PSII mRNA. The clone
producing competitor A mRNA was made by cloning 75 codons of an
artificial protein into EcoRI-XhoI sites of the vector pCDNA3 (Strat-
agene), followed by cloning of an optimal translation start site (Fig. 1B)
to allow expression. This plasmid was linearized with NotI, and com-
petitor A mRNA was made as for PSII mRNA. All in vitro produced
mRNAs were gel-purified and analyzed by agarose gel electrophoresis.
-globin mRNA and tobacco mosaic virus (TMV) mRNA were prepared
from the Roche Molecular Biochemicals in vitro translation kit.
The 5 WT-MH-COLL gene was made by cloning the BglII-XbaI
fragment of mouse genomic DNA clone containing 220 nt of the pro-
moter and 115 nt of the 5-UTR (a kind gift from Dr. M. Breindl) into
BglII-XbaI sites of the pGL3 vector and inserting into the above con-
struct the XbaI-BamHI fragment of human collagen 1(I) cDNA (a kind
gift from F. Ramirez). This restores the 5 stem-loop, which is identical
in mouse and human collagen 1(I) mRNA and includes the entire
coding region and 3-UTR of human collagen 1(I) cDNA. The 5 MUT-
MH-COLL gene was made identically except that a substitution of 18
nt, shown in Fig. 2A, was introduced into the mouse genomic clone
before reconstituting the full-size construct.
A riboprobe for analyzing expression from MH-COLL genes was
made by cloning the XbaI-KpnI fragment of human cDNA clone into
XbaI-KpnI of Bluscript SK vector (Invitrogen). This plasmid was lin-
earized by NotI and transcribed by T7 polymerase in the presence of
[32P]UTP as described (20).
In Vitro Translation Reactions—0.08 pmol of gel-purified mRNAs
was translated in a 50-l reaction using nuclease-treated rabbit reticu-
locyte lysate (Roche Molecular Biochemicals), according to the manu-
facturer’s instructions. In preliminary experiments 0.08 pmol of mRNA
was found to be a nonsaturation concentration of mRNA for a 50-l
reaction. Competitor mRNA was added in 10-fold molar excess (0.8
pmol) to the test mRNA prior to mixing with the lysate. Reactions were
incubated for 30 min at room temperature when a 5-l aliquot was
analyzed for luciferase activity. Incubations longer than 30 min did not
further increase luciferase activity. For the same test mRNA prepara-
tion the reaction was done with and without competitor, and the ratio
of luciferase activity was normalized to that of PSII mRNA. All exper-
iments were done with two different mRNA preparations, each done in
duplicate.
Transfection of Mov 13 Fibroblasts—Transient transfections were
done with the calcium phosphate technique using 10 g of correspond-
ing MH-COLL plasmids. 24 h after transfection, equal number of cells
were split into two dishes and incubation continued for an additional
24 h. The cells were then incubated in 0.2% serum for 24 h and either
treated with 4 ng/ml of TGF1 (R&D Systems) or left untreated for an
additional 24 h. Cells and cellular medium were collected and analyzed
by RNase protection assay or Western blot. Stably transfected Mov 13
fibroblasts were developed by transfection of MH-COLL genes and
pCDNA3 vector in a ratio of 10:1 and selection with G418 for 3 weeks.
G418-resistant cells were pooled and processed as above.
Western Blots—50 g of cellular proteins were run on 7.5% SDS-
PAGE gels under reducing or nonreducing conditions, as indicated. 100
ng of purified rat tail collagen type I (Collaborative Biomedical Prod-
ucts) was included as control. After transfer, the blots were probed with
1:1000 dilution of anti-collagen type I antibody (600-401-103, Rockland)
and developed using the ECL system (Amersham Biosciences). Cellular
medium was concentrated on Centricon 100 columns (Amicon), and
equivalent amounts (corresponding to 4  105 cells) were analyzed by
Western blot as above. For pepsin digestions, 40 l of concentrated
medium was adjusted to pH 2.5 with acetic acid and digested with 1 l
of 64,000 units/ml of pepsin (Sigma) for 30 min at room temperature.
After neutralization, the samples were analyzed by Western blot. For
collagenase digestion, 1 l of 4 units/ml of bacterial collagenase (Roche
Molecular Biochemicals) was added to 40 l of concentrated medium
and digested for 30 min at room temperature.
RNase Protection Assay—50 g of total cell RNA was simultaneously
hybridized with collagen-specific riboprobe and glyceraldehyde-3-phos-
phate dehydrogenase-specific riboprobe (Ambion), as previously de-
scribed (20). The collagen-specific band has an expected size of 145 nt,
and the glyceraldehyde-3-phosphate dehydrogenase-specific band has
an expected size of 120 nt.
RESULTS
Translation of Reporter mRNAs with Collagen 5-UTR Se-
quences—Fig. 1A shows the sequence of the 5 stem-loop of
mouse collagen 1(I) mRNA. To the right is shown the consen-
sus 5 stem-loop sequence, which can be derived from 1(I),
2(I), and 1(III) mRNAs of evolutionary distant organisms
(ranging from fish to humans). Since the sequence around the
collagen 1(I) mRNA start codon, as a part of the 5 stem-loop,
does not match the consensus sequence derived by Kozak (22,
23), one set of mRNAs was constructed to investigate how the
sequence of collagen 1(I) mRNA immediately 5 to the start
codon affects translation. Therefore, we constructed a reporter
mRNA containing only the last 25 nt of the mouse collagen
1(I) 5 stem-loop linked in-frame with a luciferase mRNA
(COLL START, Fig. 1B). In this construct the 5 stem-loop
cannot form because its 5-region was deleted, but it contains
the collagen 1(I) start codon in its natural sequence context.
Control mRNAs had a short 5-UTR of 35–36 nt without any
structural elements or short upstream open reading frames
(uORF) (PSII and COLL-OPTSTART, Fig. 1B). The COLL-
OPTSTART differs from the COLL-START mRNA by 9 nt
preceding the start codon, which were optimized to conform to
the Kozak rules, while in COLL-START they were from mouse
collagen 1(I) mRNA. PSII mRNA had a 5-UTR derived from
the pGL3 vector, which is optimized for efficient translation
and was used as control. 3 to the start codon all constructs had
the rest of the sequence of the 5 stem-loop (underlined in Fig.
1B), followed by the luciferase ORF. The mRNAs were made in2 B. Stefanovic and D. Brenner, unpublished results.
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vitro with 7mG cap, and their integrity was analyzed by agar-
ose gel electrophoresis (Fig. 1C). These mRNAs did not contain
a poly(A) tail, because of the small effect that the poly(A) tail
has on translation in vitro (21). These test mRNAs were trans-
lated in rabbit reticulocyte lysate with or without of 10-fold
molar excess of a competitor mRNA. The competitor mRNA
had the optimal start site followed by an ORF of 75 amino acids
(competitor A). The sequence of the 5-UTR of competitor A is
shown in Fig. 1B (COMP A). Without competitor A all three
test mRNAs yielded similar amounts of the luciferase protein.
However, in the presence of a 10-fold amount of competitor A
the efficiency of translation was reduced 5-fold for PSII mRNA,
19-fold for COLL-START mRNA, and 8.4-fold for COLL-OPT-
START mRNA. In Fig. 1D this result is shown normalized to
the inhibition of PSII mRNA. Because the highest inhibition
was observed when the collagen 1(I) sequence preceded the
start codon (COLL-START), we concluded that this sequence is
suboptimal in promoting translation initiation when competing
with another mRNA for the translation machinery.
Another set of reporter mRNAs was designed to address the
role of the 5 stem-loop in translation. 5 WT-SL reporter con-
tained 63 nt of the mouse collagen 1(I) 5-UTR with the 5
stem-loop in-frame with LUC, while the 5 MUT-SL reporter
had substitutions in the 5 stem-loop to abolish its formation
(Fig. 2A). Translation of these reporters was compared in vitro
to the PSII mRNA (described above) without competitor mRNA
or under competitive conditions. The integrity of the mRNAs is
shown in Fig. 2B. Without competitor, the 5 WT-SL mRNA
was translated about 3-fold less efficiently than PSII (arbitrari-
ly set as 1) and 5 SL-MUT mRNAs. The latter two were
translated with comparative efficiency (Fig. 2C). This was not
due to preferential degradation of the 5 WT-SL mRNA in the
lysate, because extraction of the RNAs from the lysate after a
1-h incubation and retranslation in fresh lysate yielded the
same result (not shown).
Next we compared translational efficiency of the 5 WT-SL
mRNA and 5 MUT-SL mRNA to PSII mRNA in the presence of
10-fold molar excess of competitor mRNAs. Three competitor
mRNAs were added in 10-fold molar excess to the reaction,
competitor A (described above), -globin mRNA, and TMV.
With competitor A 5 WT-SL reporter mRNA was translated
about 30-fold less efficiently, when compared with PSII mRNA.
5 MUT-SL mRNA was translated only 5.5-fold less efficiently
relative to PSII mRNA (Fig. 2D). When -globin mRNA was
used as competitor the respective ratios were 4.6- and 3.6-fold
(Fig. 2E). When viral RNA was used as a competitor the trans-
lation of 5 WT-SL and PSII mRNAs was not affected, while
translation of the 5MUT-SL mRNA was increased 2-fold (Fig.
2F). Based on the results in Fig. 2, we concluded that the 5
stem-loop is inhibitory for translation in vitro in the absence of
a competitor mRNA, while various competitor mRNAs have
either a strong inhibitory effect or show only a small effect. We
analyzed if reticulocyte lysates contain the 5 stem-loop binding
activity by performing gel mobility shift analysis using capped
5 stem-loop RNA or inverted 5 stem-loop RNA as probes, as
described (6). We could not detect specific binding to the 5
stem-loop (data not shown).
Expression of Collagen 1(I) Reporter Genes in Mov 13 Fi-
broblasts—Mov 13 fibroblasts were derived from mice in which
insertion of a retrovirus into the first intron of collagen 1(I)
gene had inactivated the transcription of this gene (24). Mov 13
activity was determined. The ratio of luciferase activity with and with-
out competitor mRNA was calculated and arbitrarily set as 1 for PSII
mRNA. The result shown is from two independent experiments each
performed in duplicate. The error bar  S.D. is shown.
FIG. 1. Suboptimal translation initiation site of collagen 1(I)
mRNA. A, conserved stem-loop structure (5 stem-loop) found around
translation initiation codon of fibrillar collagen mRNAs. The sequence
of the mouse collagen 1(I) 5 stem-loop is shown to the left and a
consensus sequence found in 1(I), 2(I), and 1(III) mRNAs of various
organisms is shown to the right. Translation initiation codon is in bold.
B, test mRNAs used to assess the functionality of the translation
initiation site of collagen 1(I) mRNA. Sequence of the 5-UTR of test
mRNAs is shown. This sequence is followed in frame by the luciferase
open reading frame starting from the codon 13. The start codons are in
bold letters, and the sequence derived from mouse collagen 1(I) mRNA
is underlined. Sequence of the 5-UTR of competitor A (COMP A) is also
shown. C, mRNAs shown in A were transcribed in vitro in the presence
of the cap analog 7mGpppG, gel-purified, and analyzed on agarose gel
for integrity. 0.08 pmol of RNA was loaded on the gel. Comp A is the
competitor mRNA made as above and added in 10-fold molar excess to
in vitro translation reactions. D, in vitro translation of the mRNAs
shown in B under competitive conditions. 0.08 pmol of test mRNAs was
translated in vitro or was mixed with 10-fold molar excess of competitor
A mRNA and than translated. After 30 min of incubation luciferase
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fibroblasts transcribe the 2(I) gene and thus provide a unique
opportunity to study translation of collagen type I mRNAs and
assembly of the collagen trimer when the 1(I) mRNA is en-
coded by various transgenes. Fig. 3 shows characterization of
Mov 13 fibroblasts. No collagen 1(I) polypeptides can be de-
tected by Western blot among cellular proteins of Mov 13 fibro-
blasts (Fig. 3A, lane 1). For comparison, cellular proteins of
NIH 3T3 fibroblasts and purified collagen from rat tail were
analyzed in lanes 3 and 2, respectively. Pro-1(I) (about 175
kDa) and 1(I) (about 120 kDa) peptides were seen in the NIH
3T3 sample. The antibody used did not detect the 2(I) chain.
The 1(I) monomer and higher molecular weight cross-links of
type I collagen are seen in the rat tail sample, which served as
markers.
To assess the role of the 5 stem-loop in collagen type I
synthesis in vivo we constructed two genes. One gene contained
220 nt of the promoter of the mouse collagen 1(I) gene followed
by the mouse collagen 5-UTR including the 5 stem-loop, li-
gated to the full-size human collagen 1(I) cDNA (5 WT-MH-
COLL, Fig. 3B). The gene has an open reading frame encoding
a full-size human collagen pro-1(I) polypeptide. The other
gene is identical, except it has an 18-nt mutation within the 5
stem-loop, which destroys its formation (5 MUT-MH-COLL).
This mutation does not affect the coding region of the gene, it
encodes for the identical polypeptide as the 5 WT-MH-COLL
gene. The genes were transiently transfected into Mov 13 fi-
broblasts and mRNA analyzed by RNase protection assay (Fig.
3C). Untransfected Mov 13 fibroblasts show no expression of
collagen 1(I) mRNA. Transfected cells show high level of
mRNAs transcribed from both transgenes, enabling us to study
how collagen mRNAs with the 5 stem-loop and without it are
translated in vivo.
Synthesis of Collagen Polypeptides from 5 WT-MH-COLL
and 5 MUT-MH-COLL Genes—First, we measured the intra-
FIG. 2. Inhibitory effect of the 5 stem-loop on translation in vitro. A, test mRNAs used to assess the effect of the 5 stem-loop on
translation in vitro. The 5-UTRs are shown. This sequence is followed in-frame by the luciferase open reading frame starting from the codon 13.
The start codons are in bold letters. Sequence derived from mouse collagen 1(I) mRNA is underlined with sequence of the 5 stem-loop overlined.
B, mRNAs shown in A were transcribed in vitro in the presence of cap analog 7mGpppG, gel-purified, and analyzed on agarose gel for integrity.
0.08 fmol of RNA was loaded on the gel. C, in vitro translation of the mRNAs shown in B. 0.08 fmol of test mRNAs was translated in vitro without
competitor mRNA. After 30 min of incubation, luciferase activity was determined. The luciferase activity produced by PSII mRNA was arbitrarily
set as 1. The result shown is from two independent experiments each performed in duplicate. The error bar  S.D. is shown. D, in vitro translation
of the mRNAs shown in B under competitive conditions with competitor A. The experiment was performed as in Fig. 1. The result shown is from
two independent experiments each performed in duplicate. The error bar  S.D. is shown. E, same experiment as in D, but the competitor was
-globin mRNA. F, same experiment as in D, but the competitor was tobacco mosaic virus mRNA (TMV).
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cellular steady-state levels of collagen polypeptides by Western
blot after transient transfections of 5 WT-MH-COLL and 5
MUT-MH-COLL genes into Mov 13 cells (Fig. 4A). We also
treated the cells with 4 ng/ml of active TGF1, to assess how
this profibrogenic cytokine (25, 26) would affect the expression.
The blot was done under nonreducing conditions to assess the
synthesis of disulfide-bonded collagen species. The major col-
lagen detected was the pro-1(I) chain, and both genes synthe-
sized a similar level of the peptide. Its steady-state level was
unaffected by TGF. However, the 5 WT-MH-COLL gene
yielded some of the disulfide-linked higher molecular weight
collagen species (HMW COLL), while the 5 MUT-MH-COLL
gene did not (Fig. 4, compare lanes 1 and 2 to lanes 3 and 4). We
could not distinguish, with our antibody, whether these species
were homo or hetero multimers of type I collagen, although
these collagen moieties comigrated with the collagen species
found in rat tail type I collagen (lane 5). The result suggested
that the 5 stem-loop, although an RNA element, is involved in
more efficient formation of disulfide-bonded collagen mono-
mers, suggesting better registration of collagen chains. This
prompted us to investigate if the collagen synthesized by 5
FIG. 3. Expression of collagen 1(I) genes in Mov 13 fibro-
blasts. A, characterization of collagen expression by Western blot.
Western blot with 50 g of cellular proteins of Mov 13 fibroblasts (lane
1) and NIH 3T3 fibroblasts (lane 3) and 100 ng of purified rat tail type
I collagen (lane 2). Migration of individual collagen 1(I) chains and
high molecular weight cross-linked collagen (HMW COLL) found only
in rat tail is indicated to the right. The antibody used does not recognize
2(I) chain. B, hybrid mouse-human collagen reporter genes. Mouse
collagen 1(I) promoter (220 nt) is shown as thin line, transcription
start site is indicated by arrow, mouse collagen 5-UTR and the 5
stem-loop is shown as thick lines, and human collagen 1(I) cDNA as an
interrupted thick line (5 WT-MH-COLL). The 5 MUT-MH-COLL gene
is identical except it has a substitution of 18 nt within the 5 stem-loop,
which abolishes its formation. This mutation is the same as that shown
in Fig. 2. C, expression of mouse-human collagen genes in Mov 13
fibroblasts. RNase protection assay done with 50 g of total RNA from
Mov 13 fibroblasts transiently transfected with 5 WT-MH-COLL (WT)
and 5 MUT-MH-COLL (MUT) genes. Untransfected Mov 13 fibroblasts
(Mov 13) are shown as controls. Riboprobe specific for the human
collagen 1(I) gene was hybridized simultaneously with riboprobe spe-
cific for the mouse glyceraldehyde-3-phosphate dehydrogenase gene, as
internal control. Migration of the respective protected bands is indi-
cated to the right.
FIG. 4. Synthesis of collagen 1(I) from 5 WT-MH-COLL and 5
MUT-MH-COLL genes. A, Western blot under nonreducing conditions
with 50 g of cellular proteins of transiently transfected Mov 13 fibro-
blasts as in Fig. 3. 48 h after transfections the cells were serum-starved
for 24 h and either left unstimulated () or stimulated with 4 ng/ml of
TGF1 () for an additional 24 h. As a control rat tail collagen was run
in lane 5. Migration of high molecular weight collagen (HMW COLL)
and individual 1(I) chains is shown to the right. B, secretion into
cellular medium of collagen synthesized from 5 WT-MH-COLL and 5
MUT-MH-COLL genes. Western blot under reducing conditions with
equivalent amounts of cellular medium from Mov 13 fibroblasts tran-
siently transfected as in A. Lane 1 is rat tail collagen as size marker.
Migration of high molecular weight collagen (HMW COLL) and indi-
vidual 1(I) chains is shown to the left. C, collagen secretion by stably
transfected Mov 13 fibroblasts. After 3 weeks of selection for stably
transfected cells, pools of cells were combined and analyzed as in B.
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WT-MH-COLL mRNA is more efficiently secreted into the cel-
lular medium.
We collected the cell medium and analyzed the equivalent
amounts by Western blot under reducing conditions. Very little
of pro-1(I) polypeptide (175 kDa) was secreted out of non-
stimulated cells and in the same amount for 5 WT-MH-COLL
and 5 MUT-MH-COLL genes (Fig. 4B, lanes 2 and 4). Only
tracing amounts were processed to mature 1(I) chain of about
120 kDa. With TGF1 stimulation a much higher amount of
pro-1(I) chain was found in the cellular medium, but both
genes produced similar amount of the protein (lanes 3 and 5).
Since there was no change in mRNA level with TGF1 stimu-
lation (not shown), we concluded that TGF1-stimulated trans-
lation or secretion of type I collagen independent of the 5
stem-loop. Alternatively, TGF may have decreased extracel-
lular degradation of collagen. In stably transfected Mov 13
fibroblasts TGF1 also stimulated extracellular accumulation
of collagen, but no difference between the 5 WT-MH-COLL and
5 MUT-MH-COLL genes was seen (Fig. 4C).
Only the 5 WT-MH-COLL Gene Expresses Properly Folded
Collagen—Next, we probed the structure of secreted collagen
from Mov 13 fibroblasts by digestion of cellular medium with
pepsin and collagenase. We used the medium of cells treated
with TGF1, because it contained the higher amount of colla-
gen that facilitated the analysis. The medium was subjected to
digestion with pepsin and collagenase as described under “Ma-
terial and Methods” and analyzed by Western blot. In undi-
gested medium under reducing conditions, the predominant
collagen species was the pro-1(I) chain (Fig. 5A, lane 1). When
the medium of cells expressing the 5 WT-MH-COLL gene was
digested with pepsin the molecular mass of this chain was
reduced to about 120 kDa (lane 2). This suggests cleavage of the
globular domains, but folding of the core domain into pepsin-
resistant triple helix. When the medium was digested with
bacterial collagenase, no collagen peptides could be detected,
suggesting the specificity of the bands (lane 3). Thus, mRNA
with the 5 stem-loop directs synthesis of triple helical collagen,
which accumulated in the cell medium. When the medium of 5
MUT-MH-COLL-expressing cells was digested with pepsin no
pepsin-resistant fragment was obtained (lane 5), although the
amount of collagen secreted was comparable to that of the 5
WT-MN-COLL gene (lane 4). Thus, mRNA without the 5 stem-
loop directs synthesis of structurally aberrant collagen that
could not resist limited pepsin digestion. Digestion with colla-
genase served as the specificity control (lane 6). The result
obtained with the medium from stably transfected Mov 13 cells
is shown in Fig. 5B. Again, the 5 WT-MH-COLL gene yielded
secreted triple helical collagen (lane 2), while the 5 MUT-MH-
COLL gene produced a pepsin-sensitive collagen (lane 5). We
concluded from these experiments that the 5 stem-loop is
necessary for productive collagen synthesis and, although it
was mutated without affecting the coding region of the mRNA,
has a profound effect on collagen protein folding or stability.
DISSCUSSION
Unique features of the three fibrillar collagen mRNAs, 1(I)
mRNA, 2(I) mRNA, and 1(III) mRNA, is the 5 stem-loop
structure that encompasses the start codon (3). The 5 stem-
loop has an important role in regulating 1(I) mRNA stability
(3, 6, 7) and is conserved in collagen mRNAs of evolutionary
distant species (4, 5). Since the start codon is part of this
stem-loop, the sequence constraints required to maintain the 5
stem-loop dictate the sequence around translation initiation.
Therefore, the start codon in collagen mRNAs is not in the
sequence context necessary for optimal translation initiation
(22, 23). We have shown here that it is not efficiently recog-
nized in vitro if more than one mRNA species are competing for
the translation machinery. When the start codon was opti-
mized we could increase translation 4-fold under competitive
conditions (Fig. 1C). The 5 stem-loop structure has a stability
of 25–30 kcal/mol. This is insufficient to block scanning ribo-
somes to reach the start codon, because stem-loop structures of
about 70 kcal/mol are needed (27, 28). Nevertheless, reporter
mRNA with the 5 stem-loop (5 WT-SL) was translated 3-fold
less efficiently, even in the absence of competitor, than similar
mRNA in which the stem-loop was mutated (5 MUT-SL, Fig.
2C). It seems that the structure of the 5 stem-loop together
with its suboptimal translation start site is responsible for this
effect.
Various competitor mRNAs inhibit in vitro translation of a
reporter mRNA with collagen 1(I) 5 stem-loop (5WT-SL) to a
different degree. Competitor A inhibited translation of 5
WT-SL mRNA 30-fold relative to a control mRNA (PSII) and
6-fold relative to the identical mRNA without the stem-loop (5
MUT-SL) (Fig. 2D). -globin mRNA had a smaller effect. Viral
mRNA showed no inhibition on 5 WT-SL mRNA, while 5
MUT-SL mRNA is translated better. The reason for this is
unclear, but TMV mRNA with its Omega sequence may titrate
an inhibitor of translation (29). The result with competitors
corroborates the finding that the 5 stem-loop may compromise
translation of collagen 1(I) mRNA, which may be a weak
substrate for translation in the absence of its RNA-binding
proteins. Since the 5 stem-loop binds protein factors in colla-
gen-producing cells, it is possible that binding of these factors
regulates translation of collagen 1(I) mRNA. Cloning of these
proteins and their addition to the in vitro translation reaction
will address this question.
Previous reports suggested that N- and C-terminal peptides
of type I collagen inhibit translation of collagen 1(I) mRNA
(30, 31). We did not see any inhibition when these recombinant
peptides were added to the in vitro translation reaction (data
not shown). Also, the 1(I), 2(I), and 1(III) collagen mRNAs
contain two short uORF preceding the start codon. We did not
see any change in translation of our reporter mRNAs in vitro
when these uORF were abolished (data not shown). Although it
is known that uORFs can regulate translation in yeast (32, 33),
there are only a few examples of their role in translational
regulation in higher organisms (34–36).
FIG. 5. Pepsin-resistant collagen was produced by the 5 WT-
MH-COLL gene. A, Mov 13 fibroblasts were transiently transfected
with 5 WT-MH-COLL (WT, lanes 1–3) and 5 MUT-MH-COLL (MUT,
lanes 4–6). After treatment with TGF, cellular medium was analyzed
by Western blot under reducing conditions. Lanes 1 and 4 are undi-
gested medium, lanes 2 and 5 are medium digested with 1000 units of
pepsin and lanes 3 and 6 are medium digested with 4 units of collagen-
ase. Migration of pro-1(I) chain and triple helical core (THC) of type I
collagen is indicated to the left. B, identical experiment as in A, but
performed with the medium of stably transfected Mov 13 fibroblasts.
Role of the 5 Stem-Loop in Translation of Collagen 1(I) mRNA932
Based on electron microscopy data, assembly of the collagen
type I heterotrimer occurs on the membrane of the endoplasmic
reticulum, while the individual chains are still associated with
polysomes or shortly after their release (14, 17). Lysyl hydrox-
ylase, one of the key enzymes in collagen modifications, is also
associated with the membrane of the endoplasmic reticulum
(37). Membrane association may couple folding starting from
the C terminus of collagen chains, to concomitant modifications
of the selected lysine residues. For collagen type I, this implies
that 1(I) and 2(I) chains may be synthesized by ribosomes
positioned in close proximity on the endoplasmic reticulum
membrane. Such coordinated translation would greatly in-
crease local concentration of the chains. We hypothesized that
the sequence elements that modulate loading of ribosomes on
collagen 1(I) mRNA may be involved in targeting for such
coordinated translation. Therefore, we mutated the 5 stem-
loop and analyzed production of collagen trimers in vivo from
the hybrid mouse-human collagen genes (5 WT-MH-COLL and
5 MUT-MH-COLL) (Fig. 5). The human collagen 1(I) gene
could rescue the phenotype of Mov 13 mice, proving that hu-
man collagen 1(I) polypeptide is functional in mouse (38, 39).
The 5 WT-MH-COLL gene produced triple helical collagen in
Mov 13 fibroblasts; however, the 5 MUT-MH-COLL gene pro-
duced collagen, which was sensitive to digestion with pepsin
(Fig. 5). The structurally aberrant collagen was produced al-
though the 5 MUT-MH-COLL gene had the identical coding
region. This pepsin-sensitive collagen may represent individual
1(I) chains, which were not efficiently folded into triple helix
and were secreted as monomers, or alternatively, the mono-
mers were not properly modified and an unstable triple helix
was secreted. The 5 MUT-MH-COLL chains had identical
electrophoretic mobility to the 5 WT-MH-COLL chains, ex-
cluding a major difference in post-translational modification,
although subtle differences may remain undetected. If the
chains were not efficiently folded, the 5 stem-loop may be
required to increase their local concentration, which would
facilitate the chain registration. The result shown in Fig. 4
where the 5 WT-MH-COLL gene produced more disulfide-
linked high molecular weight collagen suggests that this may
be the case. If the chains were not properly modified, the 5
stem-loop may target collagen mRNAs for translation to dis-
crete regions of the endoplasmic reticulum where there is op-
timal concentration of collagen-specific modifying enzymes and
molecular chaperones (40). Although we do not have direct
evidence for this, we think that the 5 stem-loop also couples
the translational machinery to the rest of the collagen biosyn-
thetic pathway, because collagen biosynthesis requires coordi-
nate action of translational apparatus, modifying enzymes, and
molecular chaperones (41). In patients with OI, where folding
of collagen type I chains is impaired, the mutant chains are
hypermodified and subjected to degradation (19, 42). Interest-
ingly, one patient with OI type I was described who had a
mutation in the 5 stem-loop in the absence of any other mu-
tation of the collagen 1(I) gene (43).
There are many examples that mRNAs are targeted for
translation at discrete subcellular sites to produce proteins
with the concentration gradient within the cell. Most targeting
signals are located in the 3-UTR of these mRNAs (44). To our
knowledge this is the first example that a RNA element located
in the 5-UTR is involved in synthesis of a secreted multisub-
unit protein. This study demonstrates that the conserved col-
lagen 5 stem-loop has specific functions. In the absence of
RNA-binding proteins, the 5 stem-loop renders the collagen
mRNAs inefficient for translation and therefore susceptible to
regulation, such as by TGF. In collagen-producing cells, the 5
stem-loop has a novel function of directing the post-transla-
tional modification of collagen to produce mature triple helices.
The 5 stem-loop almost certainly acts through its cognate
RNA-binding proteins. Cloning of these protein factors will
help us elucidate the complex biosynthesis of type I collagen.
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